-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BzMIakgu3HQIUNIkbHBVrRdsY5PXcCCd3w6tAJJEY2a7FvdnAgFugGrmF+4grnb7 zENodCDYOUjkZcxp4l79Rw== 0001104659-05-018890.txt : 20050428 0001104659-05-018890.hdr.sgml : 20050428 20050428165700 ACCESSION NUMBER: 0001104659-05-018890 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20050428 DATE AS OF CHANGE: 20050428 EFFECTIVENESS DATE: 20050428 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ABGENIX INC CENTRAL INDEX KEY: 0001052837 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943248826 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-124426 FILM NUMBER: 05781368 BUSINESS ADDRESS: STREET 1: 6701 KAISER DRIVE CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 5106086500 MAIL ADDRESS: STREET 1: 6701 KAISER DRIVE CITY: FREMONT STATE: CA ZIP: 94555 S-8 1 a05-7375_1s8.htm S-8

As filed with the Securities and Exchange Commission on April 28, 2005

Registration No. 333-              

 

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM S-8

 

REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933

 


 

ABGENIX, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware 

 

94-3248826

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer Identification Number)

 

6701 Kaiser Drive
Fremont, California 94555
(510) 608-6500

 

(Address, including ZIP Code and Telephone Number,
Including Area Code, of Principal Executive Offices)

 

1998 Employee Stock Purchase Plan

 

(Full Title of the Plan)

 

William R. Ringo
Chief Executive Officer
Abgenix, Inc.
6701 Kaiser Drive

Fremont, California 94555
(510) 608-6500

 

(Name, Address Including Zip Code and Telephone Number Including Area Code

of Agent for Service of Process)

 


 

Copies to:

 

Donald R. Joseph, Esq.

 

Stephen W. Fackler, Esq.

Senior Vice President, General Counsel and Secretary

 

Janice K. Choi, Esq.

Abgenix, Inc.

 

Simpson Thacher & Bartlett LLP

6701 Kaiser Drive

 

3330 Hillview Avenue

Fremont, CA 94555

 

Palo Alto, CA 94304

(510) 608-6500

 

(650) 251-5000

 


 

CALCULATION OF REGISTRATION FEE

 

 

 

 

 

 

 

 

 

 

 

Title of Securities to be Registered

 

Amount
to be Registered
(1) (2)

 

Proposed
Maximum
Offering
Price Per
Share(3)

 

Proposed
Maximum
Aggregate
Offering Price
(3)

 

Amount of Registration Fee
(3)

 

1998 Employee Stock Purchase Plan, Common Stock, par value $0.0001 per share

 

900,000

 

$5.70

 

$5,130,000.00

 

$603.80

 

 

(1)   This registration statement covers, in addition to the number of shares of Common Stock stated above, options and other rights to purchase or acquire the shares of Common Stock covered by the prospectus or Plan.

 

(2)   Pursuant to Rule 416(a), this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or similar transaction effected without the receipt of consideration which results in an increase in the number of outstanding shares of Abgenix, Inc. Common Stock.

 

(3)   Pursuant to Rule 457(h), because the price of the shares to be issued pursuant to the Plan is not currently determinable, the maximum offering price, per share and in the aggregate, and the registration fee were calculated based upon 85% of the average of the high ($6.82) and low ($6.60) sale prices of Abgenix, Inc. Common Stock as reported on the Nasdaq National Market System on April 22, 2005 (which is a date within five business days of the date of filing of this registration statement).  The average of the high and low sale prices has been multiplied by 85% in order to reflect the discount applicable to purchases made under the 1998 Employee Stock Purchase Plan.

 

The registration statement will become effective upon filing in accordance with Rule 462(a) under the Securities Act.

 



 

INTRODUCTION

 

Abgenix, Inc. (the “Registrant”) is filing this Registration Statement on Form S-8 to register 900,000 shares of Common Stock issuable under the Registrant’s 1998 Employee Stock Purchase Plan.

 

PART I

 

INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

 

Item 1.    Plan Information.

 

The documents containing the information specified in Part I will be sent or given to employees as specified by Rule 428 (b)(1) of the Securities Act of 1933, as amended (the “Securities Act”). Such documents are not being filed with the Securities and Exchange Commission (the “SEC”) either as part of this Registration Statement or as prospectus supplements pursuant to Rule 424 of the Securities Act. These documents and the documents incorporated by reference in this Registration Statement pursuant to Item 3 of Part II hereof, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.

 

PART II

 

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

 

The contents of the Registrant’s Registration Statement on Form S-8 filed with the SEC on October 23, 1998 (File No. 333-66055) and September 8, 2000 (File No. 333-45426) are incorporated by reference herein.

 

Item 3.    Incorporation of Documents by Reference

 

The following documents filed with the SEC are hereby incorporated by reference:

 

(a)                                  The Registrant’s latest annual report on Form 10-K filed pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), containing audited financial statements for the Registrant’s latest fiscal year ended December 31, 2004, filed on March 16, 2004.

 

(b)                                 All other reports filed pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) since December 31, 2004.

 

(c)                                  The description of the Registrant’s Common Stock contained in the Registration Statement on Form 8-A filed pursuant to Section 12 of the Exchange Act on May 5, 1998.

 

(d)                                 The description of the Registrant’s Preferred Share Purchase Rights contained in Amendment No. 3 to the Registration Statement on Form 8-A filed pursuant to Section 12 of the Exchange Act on October 29, 2003.

 

Item 5.    Not applicable.

 

 

2



 

Item 8.    Exhibits

 

The following exhibits are filed as part of this Registration Statement:

 

Exhibit No.

 

Description

4.1(1)

 

Abgenix, Inc. 1998 Employee Stock Purchase Plan, including forms of Subscription Agreement and Notice of Withdrawal

4.2(2)

 

Amended and Restated Preferred Shares Rights Agreement, between Abgenix, Inc. and Mellon Investor Services LLC, as Rights Agent, dated May 9, 2002

4.3(3)

 

Amendment No. 1 to Amended and Restated Preferred Shares Rights Agreement, between Abgenix, Inc. and Mellon Investor Services LLC, dated October 29, 2003

5.1

 

Opinion of Counsel

23.1

 

Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm

23.2

 

Consent of Counsel (included in Exhibit 5.1)

24.1

 

Power of Attorney (included on the signature page of this Registration Statement)


(1)                                  Incorporated by reference to the same exhibit filed with the Registrant’s Registration Statement on Form S-1, filed April 3, 1998 (File No. 333-49415).

 

(2)                                  Incorporated by reference to the same exhibit filed with the Registrant’s Registration Statement on Form 8-A, filed May 14, 2002 (File No. 000-24207).

 

(3)                                  Incorporated by reference to the same exhibit filed with the Registrant’s Amendment No. 3 to its Registration Statement on Form 8-A, filed October 29, 2003 (File No. 000-24207).

 

3



 

SIGNATURE

 

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Fremont, State of California, on April 27, 2005.

 

 

ABGENIX, INC.

 

By:

/s/ H. WARD WOLFF

 

 

 

Name: H. Ward Wolff

 

 

Title: Chief Financial Officer and Senior Vice President, Finance

 

SIGNATURES AND POWER OF ATTORNEY

 

The officers and directors of Abgenix, Inc. whose signatures appear below, hereby constitute and appoint William R. Ringo and H. Ward Wolff, and each of them, their true and lawful attorneys and agents, with full power of substitution, each with power to act alone, to sign and execute on behalf of the undersigned any amendment or amendments to this Registration Statement on Form S-8, and each of the undersigned does hereby ratify and confirm all that each of said attorney and agent, or their, his or her substitutes, shall do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities indicated on April 27, 2005.

 

Signature

 

Title

 

Date

/s/ R. SCOTT GREER

 

Chairman of the Board

 

April 27, 2005

R. Scott Greer

 

 

 

 

/s/ WILLIAM R. RINGO

 

Chief Executive Officer, President and Director

 

April 27, 2005

William R. Ringo

 

(Principal Executive Officer)

 

 

/s/ H. WARD WOLFF 

 

Chief Financial Officer and Senior Vice President,

 

April 27, 2005

H. Ward Wolff

 

Finance (Principal Financial and Accounting Officer)

 

 

/s/ M. KATHLEEN BEHRENS, PH.D. 

 

Director

 

 April 27, 2005

M. Kathleen Behrens, Ph.D.

 

 

 

 

/s/ RAJU S. KUCHERLAPATI, PH.D. 

 

Director

 

April 27, 2005

Raju S. Kucherlapati, Ph.D.

 

 

 

 

/s/ MARK B. LOGAN

 

Director

 

April 27, 2005

Mark B. Logan

 

 

 

 

/s/ THOMAS G. WIGGANS 

 

Director

 

April 27, 2005

Thomas G. Wiggans

 

 

 

 

/s/ RAYMOND M. WITHY, PH.D. 

 

Director

 

April 27, 2005

Raymond M. Withy, Ph.D.

 

 

 

 

 

 

4



 

EXHIBIT INDEX

 

Exhibit No.

 

Description

4.1(1)

 

Abgenix, Inc. 1998 Employee Stock Purchase Plan, including forms of Subscription Agreement and Notice of Withdrawal

4.2(2)

 

Amended and Restated Preferred Shares Rights Agreement, between Abgenix, Inc. and Mellon Investor Services LLC, as Rights Agent, dated May 9, 2002

4.3(3)

 

Amendment No. 1 to Amended and Restated Preferred Shares Rights Agreement, between Abgenix, Inc. and Mellon Investor Services LLC, dated October 29, 2003

5.1

 

Opinion of Counsel

23.1

 

Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm

23.2

 

Consent of Counsel (included in Exhibit 5.1)

24.1

 

Power of Attorney (included on the signature page of this Registration Statement)


(1)                                  Incorporated by reference to the same exhibit filed with the Registrant’s Registration Statement on Form S-1, filed April 3, 1998 (File No. 333-49415).

 

(2)                                  Incorporated by reference to the same exhibit filed with the Registrant’s Registration Statement on Form 8-A, filed May 14, 2002 (File No. 000-24207).

 

(3)                                  Incorporated by reference to the same exhibit filed with the Registrant’s Amendment No. 3 to its Registration Statement on Form 8-A, filed October 29, 2003 (File No. 000-24207).

 

 

5


EX-5.1 2 a05-7375_1ex5d1.htm EX-5.1

 

EXHIBIT 5.1

 

[SIMPSON THACHER & BARTLETT LLP LETTERHEAD]

 

April 28, 2005

 

 

Abgenix, Inc.

6701 Kaiser Drive

Fremont, California 94555

 

 

Ladies and Gentlemen:

 

 

We have acted as counsel to Abgenix, Inc., a Delaware corporation (the “Company”), in connection with the Registration Statement on Form S-8 (the “Registration Statement”) filed by the Company with the Securities and Exchange Commission under the Securities Act of 1933, as amended, relating to 900,000 shares (the “Shares”) of Common Stock, par value $0.0001 per share, of the Company, which are to be issued by the Company pursuant to the 1998 Employee Stock Purchase Plan (the “Plan”).

 

We have examined the Registration Statement, a form of the share certificate, and the Plan.  We also have examined the originals, or duplicates or certified or conformed copies, of such records, agreements, instruments and other documents and have made such other and further investigations as we have deemed relevant and necessary in connection with the opinions expressed herein.  As to questions of fact material to this opinion, we have relied upon certificates of public officials and representations of officers and representatives of the Company.

 

In rendering the opinion set forth below, we have assumed the genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as duplicates or certified or conformed copies, and the authenticity of the originals of such latter documents.

 

Based upon the foregoing, and subject to the qualifications and limitations stated herein, we are of the opinion that (1) the Shares have been duly authorized and (2) upon (a) the issuance of the Shares in accordance with the terms of the Plan under which the right to acquire the Shares is granted and (b) the payment of the consideration therefor pursuant to the terms of such Plan, the Shares will be validly issued, fully paid and nonassessable.

 

We do not express any opinion herein concerning any law other than the Delaware General Corporation Law (including the statutory provisions, all applicable provisions of the Delaware Constitution and reported judicial decisions interpreting the foregoing).

 

We hereby consent to the filing of this opinion letter as Exhibit 5.1 to the Registration Statement.  Except as stated herein, this opinion letter may not be relied upon by you for any other purpose, or relied upon by, or furnished to, any other person, firm or corporation without our prior written consent.

 

 

Very truly yours,

 

 

 

/s/ Simpson Thacher & Bartlett LLP

 

 

 

SIMPSON THACHER & BARTLETT LLP

 

 


 

EX-23.1 3 a05-7375_1ex23d1.htm EX-23.1

 

EXHIBIT 23.1

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference of the Registration Statement (Form S-8) pertaining to the Abgenix, Inc. 1998 Employee Stock Purchase Plan of our reports dated February 25, 2005, with respect to the consolidated financial statements of Abgenix, Inc., Abgenix Inc.’s management’s assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of Abgenix, Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2004, filed with the Securities and Exchange Commission.

 

 

/s/ ERNST & YOUNG LLP

 

 

Palo Alto, California

April 25, 2005

 


-----END PRIVACY-ENHANCED MESSAGE-----